However, in our TBE cohort, we observed lower serum MR-proADM levels, while CSF MR-proADM levels correlated with total CSF protein (r = 0.53), a marker of blood–CSF barrier permeability. The gene discussed is NR3C2; the disease is tick-borne encephalitis.